Pygopus 1: A Potential Drug Target and Biomarker for Various Diseases

Target Name: PYGO1

NCBI ID: G26108

PYGO1

Pygopus 1: A Potential Drug Target and Biomarker for Various Diseases

Pygopus 1, also known as PYGO1, is a protein that is expressed in the skin, hair, and nails of many organisms, including humans. It is a member of the Pygopus gene family, which is characterized by the presence of a single exon in the coding region of the gene.

Pygopus 1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and expression pattern have made it an attractive target for researchers to study and develop new treatments.

The Pygopus 1 protein is composed of 191 amino acid residues and has a calculated molecular mass of 21.9 kDa. It is expressed in the skin, hair, and nails of many organisms, including humans, and is involved in various cellular processes such as cell adhesion , migration, and signaling.

One of the unique features of Pygopus 1 is its structure. It is a single-chain protein that consists of a catalytic domain, a transmembrane region, and an extracellular region. The catalytic domain is the part of the protein that is involved in catalyzing chemical reactions, such as the formation of covalent bonds or the breaking of bonds. The transmembrane region is the part of the protein that spans the cell membrane and is involved in the regulation of the movement of substances into and out of the cell. The extracellular region is the part of the protein that interacts with the environment outside the cell.

Pygopus 1 has been shown to play a role in various diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that Pygopus 1 is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer . This suggests that it may be a useful biomarker for these diseases and could also be a potential drug target.

In addition to its potential as a drug target, Pygopus 1 has also been identified as a potential biomarker for certain diseases. For example, studies have shown that Pygopus 1 is downregulated in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder. This suggests that it may be a useful biomarker for Alzheimer's disease and could also be a potential drug target.

Pygopus 1 has also been shown to be involved in the regulation of cellular processes in the skin, hair, and nails. For example, studies have shown that Pygopus 1 is involved in the regulation of cell growth and differentiation in the skin, and that it plays a role in the development and maintenance of hair and nails. This suggests that it may be a useful target for treatments for skin, hair, and nail disorders.

In conclusion, Pygopus 1 is a protein that is expressed in the skin, hair, and nails of many organisms and is involved in various cellular processes. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new treatments for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. While further research is needed to fully understand the role of Pygopus 1 in these diseases, its potential as a drug target and biomarker makes it an important molecule to study.

Protein Name: Pygopus Family PHD Finger 1

Functions: Involved in signal transduction through the Wnt pathway

The "PYGO1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PYGO1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets